About ReNAgade
ReNAgade is a company based in Cambridge (United States) founded in 2021 was acquired by Orna in May 2024.. ReNAgade has raised $300 million across 1 funding round from investors including Orna, Turmeric Acquisition Corp and F2 Ventures. The company has 136 employees as of December 31, 2022. ReNAgade operates in a competitive market with competitors including Stoke Therapeutics, Vico, MiNA Therapeutics, Ribometrix and Creyon Bio, among others.
- Headquarter Cambridge, United States
- Employees 136 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Renagade Therapeutics Management, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of ReNAgade
ReNAgade has successfully raised a total of $300M through 1 strategic funding round. The most recent funding activity was a Series A round of $300 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $300.0M
-
First Round
First Round
(23 May 2023)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Series A - ReNAgade | Valuation | MPM Capital , F2 Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ReNAgade
ReNAgade has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Orna, Turmeric Acquisition Corp and F2 Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Invests in biotech firms developing life-saving drugs and technologies.
|
Founded Year | Domain | Location | |
|
Technologies for producing circular RNA therapeutics are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ReNAgade
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ReNAgade
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Renagade Comparisons
Competitors of ReNAgade
ReNAgade operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Stoke Therapeutics, Vico, MiNA Therapeutics, Ribometrix and Creyon Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of antisense oligonucleotide drugs for treating inherited diseases by targeting RNA splicing
|
|
| domain | founded_year | HQ Location |
RNA modulating therapies for genetic neurological diseases are developed.
|
|
| domain | founded_year | HQ Location |
Small activating RNA therapeutics are developed to restore gene function.
|
|
| domain | founded_year | HQ Location |
RNA-targeted drug discovery platform using three-dimensional structural analysis is provided.
|
|
| domain | founded_year | HQ Location |
Oligonucleotide-based drug development platform is provided using AI models.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Renagade
Frequently Asked Questions about ReNAgade
When was ReNAgade founded?
ReNAgade was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is ReNAgade located?
ReNAgade is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Who is the current CEO of ReNAgade?
Amit Munshi is the current CEO of ReNAgade.
Is ReNAgade a funded company?
ReNAgade is a funded company, having raised a total of $300M across 1 funding round to date. The company's 1st funding round was a Series A of $300M, raised on May 23, 2023.
How many employees does ReNAgade have?
As of Dec 31, 2022, the latest employee count at ReNAgade is 136.
What does ReNAgade do?
ReNAgade was founded in 2021 and is based in Cambridge, United States. RNA-based medicines are developed by the company to address various diseases. Novel RNA delivery platforms are combined to enable coding, editing, and gene insertion functionalities. Operations focus on advancing therapeutic innovations within the biotechnology sector, with emphasis on precise genetic modifications for medical applications.
Who are the top competitors of ReNAgade?
ReNAgade's top competitors include MiNA Therapeutics, Vico and Stoke Therapeutics.
Who are ReNAgade's investors?
ReNAgade has 3 investors. Key investors include Orna, Turmeric Acquisition Corp, and F2 Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.